MedMSL Secures Tens of Millions in Series A Funding, Exporting Chinese-Made Medical Devices to 204 Countries

VCBeat has learned that, recently, an S2b company specializing in the overseas expansion of medical devices—MedSingLongAnnounced the completion of tens of millions of yuan in Series A financing, with this round led byChengwei CapitalInvestment,Qingjie CapitalServing as the exclusive financial advisor. The funds will be used for corporate brand building, overseas market expansion, and R&D of an AI data platform. Previously, the company completed an angel round financing of several million yuan in 2017 and a Pre-A round financing of tens of millions of yuan in 2019.

MedSingLong is among the first batch of Chinese enterprises to venture into the global market for medical devices. As an S2b cross-border e-commerce company specializing in the overseas expansion of medical devices, its product portfolio primarily consists of equipment and consumables for radiology and clinical laboratory departments. By curating high-quality domestic medical devices, leveraging an efficient data-driven marketing system, and providing premium after-sales services, MedSingLong aims to enhance the global influence of Chinese medical devices.

To date, MedSingLong offers over 10,000 models of medical devices and 20,000 SKUs, having established partnerships with more than 800 medical device manufacturers, including Mindray Medical, iRay Technology, and Kangzhong Medical. Since its establishment in 2013, MedSingLong has achieved a compound annual growth rate (CAGR) of 50% in revenue, successfully exporting Chinese-made medical devices to 204 countries.

China’s medical device industry has developed rapidly in recent years. Currently, domestic production has been largely achieved in the field of low-cost basic medical devices, while the innovation achievements of China’s medical device sector in high-end equipment are widely recognized. However, the industry’s rapid growth has inevitably led to more intense competition and increasing “involution.” Furthermore, as numerous medical device products have been included in the centralized volume-based procurement under the national medical insurance scheme, their prices have dropped significantly, compressing corporate profit margins. Consequently, a growing number of companies are seeking new growth opportunities overseas. In the past two years, a wave of global expansion has swept through the medical device market, spanning from high-end imaging equipment and home health monitoring instruments to smart wearable devices and telemedicine solutions.

Although the overseas expansion of medical devices is booming, it is not as simple as imagined. How to conduct marketing efficiently, cost-effectively, and precisely is a major pain point. To address this pain point,MedSingLong has established an omnichannel marketing and promotion system. By adopting a model that integrates “domestic branches + overseas branches + online promotion + big data + offline business development,” the company has achieved low-cost, precision marketing, thereby addressing the high costs and low efficiency associated with traditional marketing approaches such as in-person visits and trade shows.

Notably, the MedSingLong team possesses extensive experience in internet marketing for medical devices, effectively boosting product visibility through online promotion. It is reported that approximately 4,000 customers worldwide browse MedSingLong’s products online each day.

Furthermore, after-sales service is a critical challenge that medical device manufacturers must address when expanding overseas. Chinese manufacturers often face prolonged service cycles, high costs, and low customer satisfaction in international markets. MedSingLong helps manufacturers efficiently and promptly resolve after-sales issues for overseas hospital clients by establishing subsidiaries and overseas warehouses. Currently, the company has set up overseas warehouses and offices in eight countries, including Mexico, the United States, and the Philippines.

In the future, MedSingLong will continue to deepen its presence in the overseas medical device market, helping more medical device companies successfully expand globally. At the same time, by providing cost-effective Chinese-made medical devices, it will assist hospitals in more developing countries in reducing expenditures and lowering medical costs. Hu Xinlong, founder of MedSingLong, revealed that over the next eight years, the company will establish subsidiaries and overseas warehouses in 80 countries, aiming to build the “JD.com of the medical device export sector.”

Becoming Capital: Dong ChengxianIt stated that MedSingLong has deeply cultivated the overseas expansion of niche medical device categories, accumulating extensive experience in digital marketing within emerging markets and taking a leading position in establishing offline operations abroad. By building a digital distribution system for small and medium-sized medical device enterprises in emerging markets, it demonstrates significant supply chain advantages. The founder’s insights and practical experience in emerging markets are industry-leading. We are optimistic about MedSingLong becoming the chain leader in this niche industrial sector.

Hu Xinlong, Founder of MedSingLongMedSingLong expressed its gratitude to Mr. Dong of Chengwei Capital for his years of follow-up and current recognition. MedSingLong will collaborate closely with 50 suppliers to efficiently expand into overseas markets, and looks forward to welcoming more talented professionals dedicated to global expansion as well as fostering further cooperation with suppliers.